Cargando…

Transthyretin cardiac amyloidosis

Transthyretin amyloid cardiomyopathy (ATTR-CM) may be an under recognized cause of heart failure (HF). TTR amyloidosis can be inherited, caused by variants in the TTR gene (ATTRv) or by deposition of wild-type TTR protein (ATTRwt), leading to high mortality if untreated. We report the case of a pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomoaia, Raluca, Beyer, Ruxandra, Manole, Simona, Chirilă, Alina, Dădârlat-Pop, Alexandra, Minciună, Ioan Alexandru, Pop, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411828/
https://www.ncbi.nlm.nih.gov/pubmed/34527900
http://dx.doi.org/10.15386/mpr-2219
_version_ 1783747354926514176
author Tomoaia, Raluca
Beyer, Ruxandra
Manole, Simona
Chirilă, Alina
Dădârlat-Pop, Alexandra
Minciună, Ioan Alexandru
Pop, Dana
author_facet Tomoaia, Raluca
Beyer, Ruxandra
Manole, Simona
Chirilă, Alina
Dădârlat-Pop, Alexandra
Minciună, Ioan Alexandru
Pop, Dana
author_sort Tomoaia, Raluca
collection PubMed
description Transthyretin amyloid cardiomyopathy (ATTR-CM) may be an under recognized cause of heart failure (HF). TTR amyloidosis can be inherited, caused by variants in the TTR gene (ATTRv) or by deposition of wild-type TTR protein (ATTRwt), leading to high mortality if untreated. We report the case of a patient with hereditary TTR amyloidosis and mixed phenotype (both cardiac and neurological involvement). We highlight the importance of multimodal imaging in the evaluation of these patients, as early diagnosis and treatment might lead to better outcome.
format Online
Article
Text
id pubmed-8411828
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-84118282021-09-14 Transthyretin cardiac amyloidosis Tomoaia, Raluca Beyer, Ruxandra Manole, Simona Chirilă, Alina Dădârlat-Pop, Alexandra Minciună, Ioan Alexandru Pop, Dana Med Pharm Rep Articles Transthyretin amyloid cardiomyopathy (ATTR-CM) may be an under recognized cause of heart failure (HF). TTR amyloidosis can be inherited, caused by variants in the TTR gene (ATTRv) or by deposition of wild-type TTR protein (ATTRwt), leading to high mortality if untreated. We report the case of a patient with hereditary TTR amyloidosis and mixed phenotype (both cardiac and neurological involvement). We highlight the importance of multimodal imaging in the evaluation of these patients, as early diagnosis and treatment might lead to better outcome. Iuliu Hatieganu University of Medicine and Pharmacy 2021-08 2021-08-10 /pmc/articles/PMC8411828/ /pubmed/34527900 http://dx.doi.org/10.15386/mpr-2219 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Articles
Tomoaia, Raluca
Beyer, Ruxandra
Manole, Simona
Chirilă, Alina
Dădârlat-Pop, Alexandra
Minciună, Ioan Alexandru
Pop, Dana
Transthyretin cardiac amyloidosis
title Transthyretin cardiac amyloidosis
title_full Transthyretin cardiac amyloidosis
title_fullStr Transthyretin cardiac amyloidosis
title_full_unstemmed Transthyretin cardiac amyloidosis
title_short Transthyretin cardiac amyloidosis
title_sort transthyretin cardiac amyloidosis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411828/
https://www.ncbi.nlm.nih.gov/pubmed/34527900
http://dx.doi.org/10.15386/mpr-2219
work_keys_str_mv AT tomoaiaraluca transthyretincardiacamyloidosis
AT beyerruxandra transthyretincardiacamyloidosis
AT manolesimona transthyretincardiacamyloidosis
AT chirilaalina transthyretincardiacamyloidosis
AT dadarlatpopalexandra transthyretincardiacamyloidosis
AT minciunaioanalexandru transthyretincardiacamyloidosis
AT popdana transthyretincardiacamyloidosis